Bloomberg Law: Privacy & Data Security brings you single-source access to the expertise of Bloomberg Law’s privacy and data security editorial team, contributing practitioners,...
By Jimmy H. Koo
A medical supply order form faxed to a doctor by a company to confirm a patient’s purchase isn’t an unsolicited advertisement, a federal appeals court affirmed June 5 ( Florence Endocrine Clinic, PLLC v. Arriva Med., LLC , 2017 BL 188156, 11th Cir., No. 16-17483, 6/5/17 ).
The U.S. Court of Appeals for the Eleventh Circuit said that the faxes didn’t promote the sale of Arriva Medical LLC’s goods because they only requested information to finalize orders that had already been made.
To fall within the scope of federal Telephone Consumer Protection Act liability, a fax would have had to draw attention to the commercial availability or quality of Arriva products to promote their sale, Judge William Pryor wrote for the court.
After patients of the Florence Endocrine Clinic ordered products from Arriva, the company sent faxes to the clinic requesting that physicians complete an order form. The doctors filed a class action complaint, alleging that the faxes were “unsolicited advertisements” sent in violation of the TCPA.
Arriva supplies medical products to individuals by mail. In order to receive insurance reimbursement, individuals ordering Arriva products must obtain confirmation from their doctors that the products are necessary for their treatment. To facilitate the process, Arriva sends faxes directly to the individuals’ doctors, requesting order approval. The order forms allow patients to provide proof that they have a medical need for the products, the court said.
The appeals court agreed with the trial court that the time the doctors’ faxes were in use receiving the faxes, as well as the cost of ink and paper, represented an injury. But it also agreed that because the faxes weren’t unsolicited advertisements, there is no basis to pursue relief through the TCPA.
Edelman Combs Latturner & Goodwin LLC and Adkins Firm PC represented the clinic. King & Spalding LLP and Lightfoot Franklin & White LLC represented Arriva.
Judges Frank M. Hull and Stanley Marcus joined in the opinion.
To contact the reporter on this story: Jimmy H. Koo in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Donald Aplin at email@example.com
Full text of the court's opinion is available at http://src.bna.com/pvS.
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)